CAS: 1476039-58-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Nemolizumab REF: TM-T76724CAS: 1476039-58-3 | 100% (SEC-HPLC) - > 95% | 171.00 €~1,747.00 € | Fri 29 Nov 24 |
 | Nemolizumab REF: 3D-CLA1384CAS: 1476039-58-3 | - - - | To inquire | Tue 10 Dec 24 |
Nemolizumab
CAS:1476039-58-3
Nemolizumab (CIM331) is an anti-IL-31 receptor A monoclonal antibody for atopic dermatitis and pruritus study.
Purity:
100% (SEC-HPLC) - > 95%
Color and Shape:
Liquid
Ref: TM-T76724
| 1mg | 171.00 € | ||
| 5mg | 408.00 € | ||
| 10mg | 606.00 € | ||
| 25mg | 922.00 € | ||
| 50mg | 1,290.00 € | ||
| 100mg | 1,747.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Ref: 3D-CLA1384
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
